Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 223-230 , February 2010

Hematopoietic Stem Cell Transplantation for Refractory or Recurrent Non-Hodgkin Lymphoma in Children and Adolescents

  • Thomas G. Gross

      Affiliations

    • Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio
    • Corresponding Author InformationCorrespondence and reprint requests: Thomas G. Gross, MD, PhD, Department of Pediatrics, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205.
    • ,
  • Gregory A. Hale

      Affiliations

    • Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, Tennessee
    • ,
  • Wensheng He

      Affiliations

    • Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Bruce M. Camitta

      Affiliations

    • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Jean E. Sanders

      Affiliations

    • Department of Pediatrics, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • Mitchell S. Cairo

      Affiliations

    • Department of Pediatrics, New York Presbyterian Hospital, New York, New York
    • ,
  • Robert J. Hayashi

      Affiliations

    • Department of Pediatrics, St. Louis Children's Hospital, St. Louis, Missouri
    • ,
  • Amanda M. Termuhlen

      Affiliations

    • Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio
    • ,
  • Mei-Jie Zhang

      Affiliations

    • Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Stella M. Davies

      Affiliations

    • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    • ,
  • Mary Eapen

      Affiliations

    • Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
    • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin

Received 27 August 2009 ,Accepted 24 September 2009.

References 

  1. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med. 1996;334:1238–1248
  2. Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997;337:1259–1266
  3. Gerrard M, Cairo MS, Weston C, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Br J Haematol. 2008;141:840–847
  4. Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773–2780
  5. Cairo MS, Gerrard M, Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109:2736–2743
  6. Burkhardt B, Woessmann W, Zimmermann M, et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system–negative stage III or IV lymphoblastic lymphoma. J Clin Oncol. 2006;24:491–499
  7. Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood. 2001;97:3699–3706
  8. Laver JH, Kraveka JM, Hutchison RE, et al. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen. A Pediatric Oncology Group phase III trial. J Clin Oncol. 2005;23:541–547
  9. Brugieres L, Le Deley MC, Rosolen A, et al. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group. J Clin Oncol. 2009;27:897–903
  10. Cairo MS, Sposto R, Hoover-Regan M, et al. Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. Am J Hematol. 2003;72:53–63
  11. Cairo MS, Sposto R, Perkins SL, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003;120:660–670
  12. Atra A, Gerrard M, Hobson R, et al. Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. Br J Haematol. 2001;112:965–968
  13. Attarbaschi A, Dworzak M, Steiner M, et al. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer. 2005;44:70–76
  14. Brugieres L, Quartier P, Le Deley MC, et al. Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children. A report from the French Society of Pediatric Oncology. Ann Oncol. 2000;11:53–58
  15. Kobrinsky NL, Sposto R, Shah NR, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912. J Clin Oncol. 2001;19:2390–2396
  16. Philip T, Hartmann O, Pinkerton R, et al. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first-line therapy: a report from the Societe Francaise d'Oncologie Pediatrique. Blood. 1993;81:2003–2006
  17. Ladenstein R, Pearce R, Hartmann O, et al. High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry. Blood. 1997;90:2921–2930
  18. Sandlund JT, Bowman L, Heslop HE, et al. Intensive chemotherapy with hematopoietic stem cell support for children with recurrent or refractory NHL. Cytotherapy. 2002;4:253–258
  19. Won SC, Han JW, Kwon SY, et al. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: a report from the Korean Society of Pediatric Hematology-Oncology. Ann Hematol. 2006;85:787–794
  20. Bureo E, Ortega JJ, Munoz A, et al. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bone Marrow Transplant. 1995;15:353–359
  21. Levine JE, Harris RE, Loberiza FR, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003;101:2476–2482
  22. Woessmann W, Peters C, Lenhard M, et al. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents: a Berlin-Frankfurt-Munster Group report. Br J Haematol. 2006;133:176–182
  23. Gordon BG, Warkentin PI, Weisenburger DD, et al. Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood. 1992;80:2938–2942
  24. Fujita N, Mori T, Mitsui T, et al. The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan. Pediatr Blood Cancer. 2008;51:188–192
  25. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825–828
  26. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am. 1999;13:1091–1112viii-ix
  27. Klein JP, Moeschberger ML. Survival Analysis: Techniques of Censored and Truncated Data. New York: Springer-Verlag; 2003;
  28. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–202
  29. Andersen PK, Klein JP, Zhang MJ. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med. 1999;18:1489–1500

 Financial disclosure: See Acknowledgments on page 228.

PII: S1083-8791(09)00444-3

doi: 10.1016/j.bbmt.2009.09.021

Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 223-230 , February 2010

Article Tools

* Image Usage & Resolution